Publications
- Primary drug resistance/sensitivity in vitro and clininical outcome in ovarian cancer patients2011 | Faculty of Medicine in Hradec Králové
- Chemoresistance/chemosensitivity in vitro in ovarian cancer patients2011 | Faculty of Medicine in Hradec Králové
- Resistance/sensitivity in vitro in ovarian cancer patients2010 | Faculty of Medicine in Hradec Králové
- Chemoresistance testing of human ovarian cancer cells and its in vitro model2010 | Faculty of Medicine in Hradec Králové
- Flubendazole exhibits anti-glioblastoma effect by inhibiting STAT3 and promoting cell cycle arrest2023 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Flubendazole and mebendazole impair migration and epithelial to mesenchymal transition in oral cell lines2018 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Inositol hexaphosphate limits the migration and the invasiveness of colorectal carcinoma cells in vitro2018 | Faculty of Medicine in Hradec Králové
- The effects of beta-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice2017 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Clinical Significance of the Resistance Proteins LRP, Pgp, MRP1, MRP3, and MRP5 in Epithelial Ovarian Cancer2015 | Faculty of Medicine in Hradec Králové
- Drug Resistance and Sensitivity in Ovarian Cancer2012 | Faculty of Medicine in Hradec Králové
Loading network view...